Areas of Activity

Contact us


DirexGroup invites you to join us for interesting discussions of the latest market trends at the upcoming Congress of Japanese Men's Health on September 17-18, 2022.

A presentation of MoreNova is to take place at the upcoming Woman's Health Innovations and Inventions exhibition, July 11-12, 2022 in Tel Aviv, Israel. 

The third presentation on the latest treatment approach for Female Sexual Dysfunction (FSD), by Transvaginal Shockwave Therapy (TVST), is to be presented this week at the upcoming European Society of Sexual Medicine.

Researchers in Urology find that men infected with COVID-19 would be more likely to experience ED.

The second presentation on the latest treatment approach for Female Sexual Dysfunction and SUI, by Transvaginal Shockwave Therapy (TVST), has been accepted. 

The first of three already conducted clinical pilots, relate to using MoreNova for female Sexual Improvement and Stress Urinary Incontinence. The pilots presented at the International Continence Society (ICS) 2021 Melbourne conference.  

Vaginal treatment is the latest desirable treatment to be offered by Morenova.
Packed as a table-top, compact and lightweight device, MoreNova provides treatment for various ailments and chronic diseases long suffered by women.

MoreNova Turbo (MT) is a shockwaves device incorporating a compact and powerful energizer, in-line ultrasound localizer and easily interchangeable high-efficiency applicators.

The novel applicators are designed to respectively deliver point, linear or planar shockwaves compatible with treating urinary stones, calcified leg arteries, prostate, Chronic Kidney Disease (CKD) and more.

An exclusive and limited offer is presently being offered to clinics interested in offering treatment.
Demo proposal is for a three month period and incorporates minimum 10 patient treatments, of 10 short sessions in 5 days, and follow-up p/p.

A description of Shockwaves and PEMF relationship is presented

Page 1 of 9

Contact Us

© 2022 DirexGroup. All Rights Reserved.